Tofisopam Tablet Franchise in Ahmedabad

Anxiolytic Tablet Supplier in Mumbai

Anti-Anxiety Tablet Distributor in Delhi

Mental Health PCD Pharma Franchise in Bangalore

Tofisopam Tablet Stockist in Hyderabad
Anxiety & Stress Tablet Manufacturer & Exporter in Chandigarh

Home/Products /tofisopam-50-mg-tablet

About the Product

Description


Tofizelam 50 Tablet contains Tofisopam 50mg, a benzodiazepine derivative with anxiolytic properties used in the management of anxiety disorders, stress, and tension-related symptoms. It provides calmness and mental relaxation without causing significant sedation, making it suitable for daily therapeutic use.

This medicine belongs to the neurology and psychiatry segment and is frequently prescribed by psychiatrists and neurologists for patients with mild to moderate anxiety. Its effectiveness in controlling stress-related symptoms makes it a staple in neuropsychiatric care.

Tofisopam works by modulating GABAergic activity in the central nervous system, helping regulate mood and reduce the impact of psychological stressors. Patients benefit from improved mental balance and reduced anxiety episodes.

Available for PCD pharma franchise, bulk distribution, institutional supply, and third-party manufacturing, Tofihike 100 Tablet offers a high-demand B2B opportunity. Its presence in neuropsychiatry and mental health markets ensures recurring prescriptions and a reliable business potential across India.


Common side effects may include mild drowsiness, dizziness, headache, or gastrointestinal discomfort. Rare but serious effects can include allergic reactions, agitation, or changes in blood pressure. Patients should consult their doctor if any severe or persistent side effects occur.

Tofizelam 50 Tablet is indicated for the treatment of anxiety disorders, psychosomatic conditions, tension-related disorders, and as supportive therapy in patients experiencing stress-induced symptoms.

Tofizelam 50 Tablet should be taken strictly as prescribed by a healthcare professional. Avoid alcohol and other central nervous system depressants during treatment. Caution is advised in patients with a history of liver or kidney disease, depression, or seizure disorders.

Store Tofizelam 50 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Tofisopam 50mg Tablet in the PCD pharma franchise market?

Tofisopam 50mg Tablet has growing demand in the psychiatry, mental healthcare, neurology, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric medicine portfolios.

Why should medical distributors include Tofisopam 50mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for anxiety and stress-related disorder management under medical supervision. Tofisopam 50mg is an anxiolytic medication belonging to the 2,3-benzodiazepine class Commonly prescribed for the management of anxiety disorders, stress-related conditions, psychosomatic symptoms, and emotional disturbances as advised by healthcare professionals Helps reduce symptoms such as nervousness, tension, irritability, and anxiety while supporting overall emotional well-being Oral tablet formulation provides convenient administration for outpatient and long-term treatment plans under physician supervision Requires individualized dosing and regular medical monitoring for optimal therapeutic outcomes Frequently utilized in psychiatry clinics, neurology centers, hospitals, and specialty mental healthcare facilities Widely prescribed by psychiatrists, neurologists, and general physicians This strengthens a comprehensive psychiatry and CNS care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tofisopam 50mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, specialty healthcare market opportunities, repeat purchases, reliable supply chain support, and attractive margins in the neuropsychiatric segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.